Chromosomal microarray analysis (CMA) is currently considered first-tier testing in pediatric care and prenatal diagnosis owing to its high diagnostic sensitivity for chromosomal imbalances. The aim ...

Over the last few years the use of next generation sequencing technologies has lead to new insights in both population and disease genetics, by providing a more complete characterization of DNA ...